Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-04-21
DOI
https://doi.org/10.1161/circulationaha.124.072756
Citations
7
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
14.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

Xinhui Ran, ANTHONY C. KEECH, Marc S. Sabatine, Narimon Honarpour et al.
7 citations
Circulation
Lipoproteins and Cardiovascular Health
14.04
article

Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial

Xinhui Ran, ANTHONY C. KEECH, Marc S. Sabatine, Narimon Honarpour, Huei Wang, Robert P. Giugliano, Brittany Weber, Peter S. Sever, André Zimerman, Sabina A. Murphy, Ana Laura Fischer Kunzler
article en
7 citations

Abstract

No abstract available for this paper.
CirculationVol. 151(20)
Brigham and Women's Hospital (US), The University of Sydney (AU), Center for Global Development (US), Amgen (United States) (US), Harvard University (US), Hospital Moinhos de Vento (BR), Lung Institute (US), Thrombolysis in Myocardial Infarction Study Group (US), National Health and Medical Research Council (AU)
Good health and well-being
Openalex Percentile: Top 1%
Lipoproteins and Cardiovascular Health
14.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.